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Over the past  decade a  substantial  body of evidence has accumulated that 
supports  the existence of functionally distinct subsets of T  lymphocytes. This 
concept has been particularly reinforced by the observations that cytolytic activity 
by T  lymphocytes correlates with recognition of (or restriction by) class I major 
histocompatibility complex (MHC) ~ gene products while T  lymphocyte helper/ 
amplifier function is associated with recognition of class II MHC gene products 
(1, 2). The association of these discrete functional activities with T  lymphocyte 
populations expressing mutually exclusive cell surface markers further supports 
this hypothesis (3). 
However, the concept that cytolytic function is a property of T  lymphocytes 
recognizing class  I MHC gene products has been called into question by obser- 
vations made with alioreactive T  lymphocytes. Several reports (4-7) in the mouse 
demonstrated the generation of cytolytic T  lymphocytes (CTL) directed to H-2I 
region products in mixed leukocyte cultures. More recently, murine alloreactive 
CTL  lines  (8,  9)  and  clones  (10,  11)  directed to  an  I-A product  have  been 
described that  express  the  Lyt-l+2  -  cell  surface phenotype.  Similarly, in  the 
human, several groups have described T4 + alloreactive CTL that recognize class 
II MHC structures (12,  15).  These results raise the possibility that cell surface 
lymphocyte markers such as Lyt-2 in the mouse or T4 in the human correlate 
with MHC recognition (or restriction) rather than T  lymphocyte function (16). 
Compared with the data demonstrating class II MHC-alloreactive CTL, there 
is much less evidence for restriction by class II MHC products in the recognition 
of nominal antigen by CTL. The earliest suggestion of class  II-restricted CTL 
This work  was  supported  by grants  AI-15608,  AI-15353,  and  HL-33319  from  the  U.  S.  Public 
Health Service, by the American Diabetes Association (V. Braciale), and Medical Scientist Training 
Program Grant 5T32GMO7200 (A. Lukacher), and by research support from Brown and Williamson 
Tobacco Corp., Philip Morris, Inc., and the United States Tobacco Company. Current address for 
B.  Malissen:  Le  Centre  d'Immunologie  INSERM-CNRS  de  Marseille-Luminy,  Case  906,  13288 
Marseille CEDEX 9, France. 
i Abbreviations used  in  this paper:  Con A, concanavalin A; CTL, cytolytic T  lymphocytes; FBS, 
fetal bovine serum; [SH]TdR, tritiated thymidine; HAT, hypoxanthine, aminopterin, thymidine; IL- 
2, interleukin 2; 2-ME, 2-mercaptoethanol; MEM, minimal essential medium; MHC, major histocom- 
patibility complex; PFC, plaque-forming centers; SRBC, sheep red blood cells; TCGF, T  cell growth 
factor; and UV, ultraviolet. 
J. ExP. MED. © The Rockefeller University Press  - 0022-1007/85/07/0171/17  $1.00  171 
Volume 162  July 1985  171-187 172  H-2I REGION-RESTRICTED ANTIVIRAL CTL  CLONES 
was a report by Wagner et al. (17) describing TNP-specific heterogeneous CTL 
populations that require I region compatibility for lysis of TNP-conjugated target 
cells. I  region-restricted  T  lymphocyte clones specific for ovalbumin and cyto- 
chrome c, which can destroy, in an  H-2-restricted manner,  target cells bearing 
these  antigens,  recently  have  been  described  by  Tile  and Janeway  (18)  and 
Norcross  et  al.  (19),  respectively.  In  at  least  one  instance  (18),  target  cell 
destruction appeared to be nonspecific and mediated by a soluble factor released 
as a result of antigen-specific recognition. In the human, class II MHC-restricted 
T  lymphocyte clones with specific cytolytic activity for virus-infected cells have 
been reported  in several viral systems (20-22)  but the possible role of soluble 
cytolytic factors as mediators of lysis has not been fully explored. 
In this study we demonstrate the expression of specific cytolytic activity by a 
panel  of murine  T  lymphocyte clones directed  to  type A  influenza  virus and 
restricted  by  H-2I-A  or  I-E  subregion-encoded  determinants.  These  clones 
express the Lyt-1 +2-, L3T4 + phenotype, proliferate in the absence of exogenous 
interleukin  2  (IL-2),  and  release  factors  that  provide  help  for  in  vitro  B  cell 
responses.  The  fine  specificity of viral  antigen  recognition  by these  clones  is 
identical  in  both  proliferation  and  cytotoxicity  assays  and  is  comparable  to 
patterns  previously  observed  with  H-2K-  or  D-restricted  antiinfluenza  CTL 
clones (23, 24). Cytolytic activity of the clones is specifically inhibitable by anti- 
Ia  antibody  or antibody to  the  L3T4  molecule.  Using  L  cells that  express  Ia 
antigens by DNA-mediated gene transfer, we further demonstrate that two CTL 
clones are restricted by the E~ chain in their  recognition  of viral antigens.  We 
also present evidence consistent with the concept that these clones mediate their 
cytotoxic  effector  function  by  direct  lysis  of virus-infected  cells  rather  than 
release of a nonspecific cytolytic factor. The implications of these findings with 
regard to the conventional distinction between helper and cytolytic T  cell subsets 
in antiviral immunity are discussed. 
Materials and Methods 
Animals.  CB6F~/J [BALB/cJ (H-2  d) × C57BL/6J (H-2b)] and BALB/cByJ mice were 
purchased from The Jackson Laboratory, Bar Harbor, ME, and used at 7-14 wk of age. 
B 10. D2 (H-2d), B 10.BDR 1 (H-294), B 10.CHR51 (H-2W'8), B l 0.A(5R) (H-2~5), and B 10.GD 
(H-2 g2) mice were generously provided by Drs. D. Shreffler and V. Hauptfeld (Department 
of Genetics, Washington  University,  St. Louis MO). 
Viruses.  Influenza  virus  strains  A/JAP/57  [A/Japan/305/57(H2N2),  A/AA/67  [A/ 
Ann  Arbor/7/67(H2N2)],  A/PR/8  [A/Puerto  Rico/8/34(H1N1), A/MEL/35  [A/Mel- 
bourne/35(H 1N 1)], A/PC/75 [A/Port Chalmers/75(H3N2), A/HK/68 [A/Hong Kong/ 
1/68(H3N2)], and  B/Lee were grown in  the allantoic  cavity of 10-d-old embryonated 
chicken eggs and stored as infectious allantoic fluid as previously described (25). 
Influenza  A/JAP/57 was concentrated and purified according to standard procedures 
(26).  Briefly,  virus  was concentrated  by adsorption-elution  of infectious  allantoic  fluid 
from human erythrocytes followed by ultracentrifugation,  and then further purified by 
velocity centrifugation over sucrose gradients. 
Purified  A/JAP/57  virus  was inactivated  by exposure  to  ultraviolet  (UV)  light,  as 
described elsewhere (27). No residual  infectious  virus  was detectable as  measured by 
absence of plaque-forming centers (PFC) on MDCK cell monolayers (28). No loss of viral 
hemagglutinating  activity,  as  measured  by the  hemagglutination  titration  method  of 
Fazekas de St. Groth and Webster (29), was observed after virus inactivation. 
Monoclonal Antibodies.  The monoclonal antibodies used in experiments to inhibit cell- LUKACHER ET  AL.  173 
mediated cytotoxicity were Do4, specific  for K  d and D  d (30);  Do3, anti-I-E  d'k (30);  MK- 
D6, anti-I-A  d (31); and GK 1.5, anti-L3T4a (32). These monoclonal antibodies were in the 
form of cell-free  sterile  culture  supernatants.  The  hybridoma GK1.5  was  generously 
provided  by Dr.  Frank  Fitch  (Department  of Pathology, The  University of Chicago, 
Chicago, IL). The rat anti-Thy-1 monoclonal antibody T24/40.7 (from the Salk Institute, 
La Jolla, CA) was concentrated 20-fold by (NH4)2SO4 precipitation of  culture supernatants, 
and used at  1:50 dilution to deplete spleen cells of T  cells for in vitro anti-SRBC (sheep 
red blood cells) antibody responses. 
Tumor Cell Lines.  The P815 (H-2  d) mastocytoma line and the A20-1.11 (H-2  d) B cell 
lymphoma line (33) were maintained in culture in Dulbecco's modified minimal essential 
medium (MEM)  (Gibco Laboratories, Grand Island, NY) supplemented with antibiotics 
and 10% fetal bovine serum (FBS). 
Construction  and Maintenance  of L  Cell Lines Expressing  E,,kEa  a and E~kEa  k Gene Prod- 
ucts.  L cell  (H-2  k) transformants CA36.2.1  and CA36.1.1, expressing products of the 
E~kEa  d genes and the E~kEa  k genes, respectively, were established by transfection of Ltk- 
cells with  DNA corresponding to the indicated gene segments, as described previously 
(40).  These  cells  were  maintained  in  hypoxanthine,  aminopterin,  thymidine  (HAT) 
medium. They express high levels of  the appropriate transfected gene products as detected 
by flow cytofluorometry  using specific monoclonai reagents (A. E. Lukacher, unpublished 
observations). 
Establishment  and Maintenance  of T  Lymphocyte Clones.  T  lymphocyte clones  were 
isolated and  maintained according to methods described in  detail  elsewhere (23).  The 
CTL clones A4, A7, 14-1, and 35-6 are all type A influenza virus-specific and restricted 
by class I MHC products. They were selected by in vitro stimulation of individual primed 
precursor cells  with  infectious  A/JAP]57  virus  (23).  The  class  II MHC-restricted  T 
lymphocyte clones discussed in  this report were either established as described for class 
I-restricted CTL, using infectious A/JAP/57 virus, or by in vitro stimulation of primed 
precursors using UV light-inactivated A]JAP]57 virus according to the method of Leung 
and Ada (34). 
Assays for Cell-mediated Cytotoxicity.  P815 cells, A20-1.11 cells, and the L cell transfec- 
tants K2, CA36.2.1, and CA36.1.1, were used as target ceils in 5~Cr release assays, which 
were carried out essentially  as described elsewhere (23). Spontaneous release from target 
cells incubated with medium alone over the 6 h  time course of the assay was generally 
<10% for P815 cells, and <20% for A20-1.11 ceils and the L cell transfectants. Release 
values represent  the  mean specific  5~Cr release  from three  replicate  wells. SEM  were 
always <5% of the mean value and are omitted. 
Inhibition of cell-mediated cytotoxicity by monoclonal antibodies was carried out as 
follows:  1 x  104 5~Cr-labeled, A/JAP/57 virus-infected A20-1.11 target cells were added 
in a 0.05 ml vol to each well of a 96-well round-bottomed microtiter plate.  Each well then 
received 0.1  ml of the indicated dilution in medium of Do4, Do3, or MK-D6 antibody 
supernatant. After incubation for 20 min at 37°C, a 0.5 ml vol containing 1 x  105 CTL 
clones was added to each well. For blocking of cytotoxicity by GK1.5 antibody, a 0.05 ml 
vol of 1 x  105 effector CTL cells  was added  to wells  containing a  0.1  ml vol of the 
appropriate dilution of antibody or control medium; the T  cells were incubated with the 
GK1.5 antibody for 20 rain at 37°C before the addition of 1 x  10451Cr-labeled,  A]JAP/ 
57 virus-infected A20-1.11 target cells in 0.05 ml. Viable effector T  cells were used 5 d 
after routine subculturing and were separated from dead cells according to the method 
of Davidson and  Parish  (35)  before inclusion  in  this assay.  All  antibody dilutions  and 
target cell and effector cell resuspensions were carried out in MEM plus 10% FBS. After 
a  6 h  incubation at  37°C, a  0.1  ml vol was removed from each well and counted in a 
Beckman 4000 Gamma Counter (Beckman Instruments, Inc., Fullerton, CA). 
Assay of Cellular Proliferation.  The proliferative response of cloned T  cell  lines  was 
assessed by [~H]thymidine ([3H]TdR) incorporation, as previously described (24).  Results 
are  expressed  as  the  mean  cpm  "4-  SEM  of quadruplicate  cultures  at  the  peak  of the 
proliferative response (day 3 of culture). 
Assays for  T  Cell  Helper  Activities.  Viable  T  cell  clones  at  day  7  after  antigenic 174  H-2I  REGION-RESTRICTED  ANTIVIRAL  CTL  CLONES 
stimulation were separated from erythrocytes and dead cells by sedimentation on Ficoll/ 
sodium metrizoate (35).  2 ×  106 cells of each clone were added to individual wells of six- 
well-cluster tissue culture plates (Costar, Cambridge, MA) containing 20 ×  106 irradiated, 
uninfected BALB/c spleen cells, inactivated A/JAP/57 virus-pulsed, BALB/c spleen cells, 
or  no  spleen  cells,  in  5  ml  of RPM1  1640  medium  supplemented  with  10%  FBS, 
nonessential amino acids (Ix) (Gibco Laboratories), 5 ×  10  -5 M 2-mercaptoethanol (2- 
ME),  2  mM glutamine, and antibiotics. After 24 h  incubation at 37°C in.a humidified 
atmosphere of 7% CO2, supernatants were collected and stored at 4°C. 
The capacity of these supernatants to promote a primary in vitro anti-SRBC response 
was examined. CB6F~/J spleen cells were T  cell-depleted by treatment with anti-Thy-1 
monoclonal antibody and guinea pig complement (Gibco Laboratories). 8 ×  106 T  cell- 
depleted  spleen  cells  were  added  in  0.2  ml  vol  RPMI  1640  containing  10%  FBS, 
nonessential amino acids (1×),  5  ×  10  -5 M  2-ME, 2  mM glutamine, and antibiotics to 
individual wells of 24-well  tissue culture plates (Linbro Chemical Co., Hamden, CT). A 
0.3 ml vol of supernatant was added per well.  Each well then received 0.03 ml of a  1% 
SRBC suspension (Colorado Serum Co., Denver, CO). Control cultures received 0.3 ml 
medium or supernatant of concanavalin A (Con A)-pulsed rat spleen cells. Cultures were 
fed daily with 0.03 ml/well of a nutritive cocktail (36).  At day 5 of culture, wells were 
harvested and assayed for an anti-SRBC antibody response in a modified Jerne hemolytic 
plaque assay  (37).  Results are expressed as the mean PFC --- SEM per culture and the 
mean PFC + SEM per 106 viable cells from individual cultures assayed in duplicate. 
IL-2 activity in the supernatants was assayed using an  IL-2-dependent murine T  cell 
clone, 14-7fd (38).  5 d after subculture in 20% T  cell growth factor (TCGF)-containing 
medium, 4 ×  104 14-7fd cells were added to each of four replicate wells of flat-bottomed, 
96-well  microtiter plates (Linbro Chemical Co.) in the presence of 50% culture superna- 
tant. The cells were incubated for 24 h, then pulsed with  1 uCi/well [3H]TdR for 16 h 
before harvest. 
Results 
Expression of Cytolytic Activity by Class H MHC-restricted,  Influenza Virus-Specific 
T Cell Clones.  In a previous report (23) we described the isolation and charac- 
terization of continuous cloned lines of influenza virus-specific T  lymphocytes. 
Most of the T  cell clones selected by this cloning strategy exhibited H-2  K/D- 
restricted, virus-specific cytolytic activity and possessed the Lyt-l±2  + phenotype. 
However,  some  Thy-I + T  lymphocyte clones  were  isolated  that  lacked  virus- 
specific cytolytic activity on conventional target cells,  e.g.,  virus-infected P815 
mastocytoma cells. 
Since  P815  cells express  H-2K  ~ and  D d region  products  but  fail  to express 
detectable cell surface H-2I  d region products,  it was of interest to examine the 
capacity of these "noncytolytic" clones to recognize and destroy Ia  + virus-infected 
target cells. Table I shows the results of such an analysis using a panel of influenza 
virus-specific T  lymphocyte clones derived from A/JAP/57-immune  mice and 
tested  on  P815  target cells and  the  H-2Id-positive A20-1.11  B  cell lymphoma 
line. Two conventional CTL clones of BALB/c origin, A4  and A7,  efficiently 
lysed A/JAP/57-infected but not uninfected or B/Lee-infected P815 cells. These 
clones  showed  comparable  cytolytic effector specificity on  A/JAP/57-infected 
histocompatible A20-1.11  ceils. The fine specificity of viral antigen recognition 
of clones A4 and A7  and their restriction by H-2K  d and  L d,  respectively, have 
been reported previously (28). As shown in Table I, of five clones that did not 
efficiently lyse A/JAP/57-infected P815 cells, three, D8, G1, and U5, exhibited 
a high degree of specific lysis on A/JAP/57-infected A20-1.11  cells but failed to LUKACHER  ET  AL. 
TABLE  I 
Cytolytic Activity of Influenza Virus-specific T Cell Clones 
175 
Percent specific S~Cr release* 
Clone  Effector/tar-  P815 targets*  A20-1.11  targets 
get ratio  Unin-  A/JAP/  B/Lee  Unin-  A/JAP/  B/Lee 
fected  57  fected  57 
A4  10:1  7  54  10  3  28  3 
1:1  0  29  t  1  13  0 
A7  10:1  9  78  12  7  35  8 
1:1  0  49  1  I  21  0 
D8  10:1  1  3  2  2  46  0 
1:1  1  0  0  1  23  0 
G1  10:1  1  6  2  8  57  6 
I:I  0  0  1  1  32  1 
U5  10:1  1  8  3  1  25  0 
l:l  1  1  0  0  14  0 
U2  10:1  1  4  1  0  11  0 
1:1  0  2  1  0  7  0 
Ull  10:1  3  13  4  0  t5  2 
1:1  I  3  0  0  5  0 
* Cloned T  cell lines were examined for cytolytic activity on uninfected and infected 51Cr-labeled 
target cells 5-6 d  after routine snbculturing (see Materials and Methods). Assay time was 6 h. 
* Values are the means of three replicate wells; SEM were <5%  of mean values and are omitted. 
Spontaneous release from P815 target groups was < 13% and from A20-1.11 target groups, < 14%. 
1 x  104 target cells were added per well. 
recognize B/Lee-infected A20-1.11  cells or A/JAP/57-infected  P815 cells to a 
significant  extent.  Two other clones,  U2 and  U I 1,  exhibited only a  marginal 
degree of lysis on either A/JAP/57-irffected A20-1.11  or P815 cells. The ability 
of clones D8, G1, and U5 to discriminate between the Ia + A20-1.11 cell line and 
the Ia-  P815 cell line  suggested that these clones represent CTL restricted by 
class II MHC products in their recognition of influenza virus-infected cells. 
Class II MHC-restricted virus antigen recognition by these clones is supported 
by several further  observations.  First,  clones D8,  G1,  U5,  U2, and  U11  were 
found,  by  flow  cytofluorometry,  to  express  the  Thy-l.2 +,  Lyt-l+2  -,  L3T4 + 
surface markers (data not shown), the phenotype characteristic of class II MHC- 
restricted T  cells (16, 32). Second, genetic mapping using congeneic and recom- 
binant inbred mouse strains established that antigen-specific stimulation of these 
clones to proliferate was restricted by class II MHC genes. As shown in Table II, 
all five H-2  d clones proliferated in response to A/JAP/57 virus-pulsed B 10.BDR 1 
spleen cells but not to A/JAP/57 virus-pulsed B10.CHR51 spleen cells, thereby 
mapping their restriction  to the H-2I  a region.  Clones U5, U2, and  U11  recog- 
nized viral antigens presented by B10.GD cells, mapping their restriction to the 
I-A  a subregion. The failure of clones G1 and D8 to proliferate in response to A/ 176  H-2I  REGION-RESTRICTED  ANTIVIRAL  CTL  CLONES 
TABLE  II 
Class lI MHC Restriction  of Cloned T Cell Proliferation 
Stimulator spleen cells* 
MHC Haplotype 
Strain 
K  Aa  Aa  Ea  E~  S  D 
Peak proliferative response ~ 
GI!  D8  U5  U2  UII 
BALB/c  d  d  d  d  d  d  d  5,541  ±  554  ND  I  ND  ND  ND 
B10.D2  d  d  d  d  d  d  d  ND  4,473 ±  130  9,896 ± 564  3,238 ±  107  8,053 ±  138 
B10.BDR1  d  d  d  d  d  d  b  1,422 ±  146  3,178 ± 468  14,918 ±  1,287  2,942 ± 208  4,864 ±  75 
B10.CHRSI  d  p  p  p  7  W5  W5  29±3  25±2  27±2  34±6  562±21 
B10.GD  d  d  d  d  b  b  b  43±10  21±3  16,227±401  2,977 ±  128  6,522±373 
b 
* Normal spleen cells after 2,000 tad of 7 irradiation were pulsed with inactivated A/JAP/57 virus as described  (Materials and Methods).  1 x 
10  6 spleen cells were cocukured with 1 X 104 cloned T cells. 
* Values are the mean cpm ± SEM of [SH]TdR  incorporation from quadruplicate cultures at the peak of the proliferative response  (day 3). 
i 6 d  after routine subculturing, cells of each  cloned line were  resuspended in fresh medium containing 10% TCGF and cultured for an 
additional 8 d. After this time, replicate  cultures of viable cells were  examined for proliferation by [SH]TdR  incorporation after culturing 
with stimulator spleen cells in the absence  of exogenous IL-2. 
I Not determined. 
TABLE  III 
Viral Antigen-specie Proliferation of Class II MHC-restricted  Clones* 
BALB/c stimulator spleen cells* 
Peak proliferative response ! 
D8  GI  U5  Ull  U2 
--  160 ±  31  269 ± 35  159 ±  5  116 ±  10  186 ±  15 
A/JAP/57 (H2N2)  7,909 -  352  7,368 ±  192  128,118  ±  10,106  17,010 ±  1,088  5,034 ± 46 
A/AA/67 (H2N2)  4,192 ±  269  3,826 ±  241  4,209 ± 379  12,182 ± 634  5,568 ±  124 
A/MEL/35 (HINI)  14,205  ± 536  133 ±  12  358 ± 80  ND !  5,286 ±  350 
A/PR]8 (HINI)  14,888 ±  716  110 ±  17  170 ±  26  ND  ND 
A]PC]75 (H3N2)  22,570 ±  1,960  112 ±  5  184 ± 33  ND  ND 
A]HK/68 (H3N2)  23,214 ± 678  107 ± 4  288 ±  24  16,922  ± 416  5,022 ± 285 
B/Lee  153 ±  26  175 ±  17  130 ±  75  411 ± 42  654 ±  31 
* See footnote * in Table I1. 
* As in Table I1, except that normal BALB/c spleen cells, after 2,000 rad irradiation, were  either infected  with the indicated virus 
strain or left uninfected.  The subtype  designations of the type A influenze  virus strains appear in parentheses. 
! As in Table II. 
I Not determined. 
JAP/57 virus-pulsed B10.GD cells tentatively mapped their restriction to the I- 
E d subregion. Finally, both the cytolytic and noncytolytic class II MHC-restricted 
clones proliferated in the absence of exogenous IL-2 after appropriate antigenic 
stimulation (Tables II and III). This result is consistent with the general finding 
that class II MHC-restricted T  cell clones exhibit antigen-dependent, but exog- 
enous IL-2-independent, growth (39). 
Viral  Antigen  Specificity  of Class  II  MHC-restricted  T  Cell  Clones.  Previous 
studies from this laboratory (23) have demonstrated that class I MHC-restricted, 
influenza-specific CTL clones exhibit several distinct categories of influenza virus 
recognition specificity: unique, subtype-specific, and crossreactive. Thus it was 
of interest  to  determine  whether similar  patterns  of virus  recognition  were 
exhibited by the class II MHC-restricted T  cell clones. 
Tables III and IV show the viral antigen specificity of the class II-restricted, 
influenza-specific clones in proliferation and cytotoxicity assays. Clones D8, U 11, 
and U2 proliferated in response to syngeneic spleen cells infected with type A 
influenza virus strains of serologically distinct subtypes [A/JAP/57(H2N2),  A/ LUKACHER ET  AL.  177 
TABLE  IV 
Influenza Virus Specificity of Class II MHC-restricted CTL Clones 
Percent specific  ~lCr release from A20-1.11 target cells* 
Clone  Uninfected B/Lee  A/JAP/57  A/AA/67  A/PC/75  A/PR/8 
(H2N2)  (H2N2)  (H3N2)  (H1N1) 
D8  1'  1  50  14  56  54 
G1  7  8  70  72  14  8 
U5  0  1  61  55  1  3 
* As in Table I. Effector/target ratio is 5:1. 
As in Table I. Spontaneous release for all target groups was <20%. 
MEL/35(H1N1), and A/HK/68(H3N2)], while clones G1 and U5 were directed 
to an antigenic determinant shared by type A influenza virus strains of the H2N2 
subtype [A/JAP/57  and A/AA/67].  None of the clones recognized uninfected 
or B/Lee virus-infected stimulator cells. Thus, clones D8, U 11, and U2 exhibited 
the crossreactive pattern  of type A  influenza  virus recognition,  and clones G1 
and  U5 displayed the  H2N2 subtype-specific pattern.  As shown in Table  IV, 
CTL clones D8,  G1, and  U5 only lysed target cells infected with the influenza 
virus  strains  that  stimulated  their  proliferation.  The  particular  viral  protein 
recognized by G1  has been unequivocally mapped to the A/JAP/57  hemagglu- 
tinin  molecule  by the  use  of Ia +  target  cells  expressing  the  products  of the 
transfected A/JAP/57 hemagglutinin  gene (Lukacher and Braciale, unpublished 
observations). Thus,  the class  II  MHC-restricted  CTL clones possess identical 
viral  antigenic  requirements  for  both  cell-mediated  cytotoxicity and  cellular 
proliferation. 
Inhibition  of Cytolytic Activity  of CTL  Clones  by Monoclonal  Antibodies  to MHC 
Determinants and Lymphocyte Surface Markers.  The  results in Table  II provide 
strong evidence that these clones are I region-restricted  in viral antigen recog- 
nition, at least in proliferation.  To further test the hypothesis that the cytolytic 
effector function  of the  D8,  G1,  and  U5  clones was likewise restricted  by Ia 
antigens, monoclonal antibodies specific for class I and class II MHC determinants 
were used to block the cytolytic activity of these clones toward A]JAP/57 virus- 
infected A20-1.11  target cells. As shown in Table V, the monoclonai antibody 
Do4, which is directed to a public determinant on K a and D O  gene products (30), 
specifically inhibited  the cytolytic function of the class I  MHC-restricted  CTL 
clones A4 and  14-1, but did not affect clones D8, G1, and U5. In contrast,  the 
monoclonal antibody Do3, which recognizes the Ia.7 epitope on I-E  a' k (30), only 
blocked target lysis by clones D8 and G 1, whose MHC restriction patterns were 
tentatively mapped to the I-E  a subregion (Table II). Interestingly, the monoclonal 
antibody  MK-D6,  which  reacts  with  I-A  a  (31),  failed  to  inhibit  the  cytolytic 
function  of clone  U5,  which  is  restricted  by  I-A  a  in  its  recognition  of viral 
antigens  (Table  II).  As  expected,  MK-D6  did  not  interfere  with  the  cytolytic 
activity of the I-Ed-restricted clones, D8 and GI. 
The L3T4 T  cell surface marker, defined by the monoclonal antibody GK1.5, 
has been reported to be involved in antigen recognition by class II-restricted T 
cells (32).  As shown  in  Table  V,  the  GK1.5  monoclonal  antibody  completely 
blocked the cytolytic activity of the L3T4a  + clones D8, G1, and U5, but not of 178  H-2I  REGION-RESTRICTED  ANTIVIRAL  CTL  CLONES 
TABLE  V 
Inhibition of Cytolytic Activity by Monoclonal Anti-Ia and Anti-L3T4 Antibodies 
Monoclonal 
antibody 
Specificity  Dilution* 
Percent specific 51Cr release from A/JAP/57 virus- 
infected A20-1.11  targets* 
A4  14-1  D8  G1  U5 
Do4  K d,  D d 
Do3  I-E  d 
MK-D6  I-A  d 
GK1.5  L3T4a 
18 (6)  4  26 (2)  20 (1)  49 (1)  32 (0) 
1/4  3  2  16  41  30 
¼6  5  5  15  43  31 
l/fi4  6  7  17  42  32 
½56  11  16  19  42  34 
¼  17  26  0  1  28 
¼6  17  26  1  3  32 
¼4  17  26  3  15  29 
½8n  22  30  21  44  37 
¼  19  29  28  53  31 
¼6  20  28  28  53  35 
¼4  20  27  25  52  38 
¼  16  23  1  8  0 
¼6  16  24  14  25  6 
%4  19  27  24  49  30 
The effect of the indicated monoclonal antibodies on the cytolytic activity of two class I  MHC- 
restricted CTL clones (A4 and 14-1) and three class II MHC-restricted CTL clones (D8, G1, and 
U5) was assayed as described (Materials and Methods). 
*  1 ×  104 target cells were added per well. The effector cell/target cell ratio was I0:1. Spontaneous 
release from target cells was <17%. Assay time was 6 h. 
* Culture supernatants of the monoclonal antibodies were diluted as indicated before addition to the 
assay, 
Values represent the means of three replicate wells; SEM are <5% of mean values and are omitted. 
Values in parentheses are the percent specific release of 51Cr-labeled uninfected A20-1.1 1 target 
cells by the indicated CTL cloned lines. 
the class I-restricted CTL clones A4 and 14-1. This is consistent with the concept 
that  the cytolytic effector activity of these clones is restricted by class II  MHC 
products. 
Recognition  of Class H MHC Product-Expressing L  Cell Transfectants by Class II 
MHC-restricted CTL Clones.  The above result strongly suggests that these clones 
recognize  virus  in  association  with  class  II  MHC  molecules  expressed  on  the 
A20-1.11  cells.  To  definitively  demonstrate  that  a  particular  class  II  MHC 
product  restricts  viral  antigen  recognition  by these  clones,  we  examined  the 
capacity of these clones to recognize L cells bearing an appropriate class II MHC 
product introduced  by DNA-mediated gene  transfer.  Two class II  MHC gene 
transfectant  lines  were  used  in  this  analysis:  CA36.2.1,  which  expresses  the 
k  d  E~E~ molecule. The suscep-  E~Ee molecule, and CA36.1.1, which expresses the  k  k 
tibility to cell-mediated lysis of these L cell lines and the control L cell line,  K2 
(transfected with the herpes virus thymidine kinase gene only), was demonstrated 
by the ability of the H-2Dk-restricted, type A influenza-specific CTL clone 35-6 
to destroy A/JAP/57  virus-infected  cells of each  L  cell  transfectant,  but  not LUKACHER  ET  AL.  179 
uninfected  or  B/Lee  virus-infected  cells  (Table  VI).  Interestingly,  the  I-E  a- 
restricted CTL  clones, D8 and G 1, recogr,  ized A/JAP/57-infected  target cells of 
the  k  a  E~Ea transfectant,  but did not lyse B/Lee-infected or uninfected cells of this 
L  cell transfectant.  Furthermore,  D8 and G1  did not lyse A/JAP/57-infected  or 
uninfected cells of either the control K2 transfectant  or of the  k  k  E~Ea transfectant 
(Table  VI,  Exp.  1).  As  expected,  the  I-Aa-restricted CTL  clone  U5  failed  to 
recognize  virus-infected or  uninfected  CA36.2.1  cells. These  findings demon- 
strate  that  CTL  clones  D8  and  G1  are  restricted  by  the  E~  chain  in  their 
recognition of influenza virus antigens on the surface of infected cells. 
Helper Function of CTL Clones.  In view of the fact that these CTL  populations 
exhibited the same MHC  restriction and growth characteristics as T  cells of the 
helper/inducer  subset, we examined the capacity of these class II MHC-restricted 
CTL  clones to provide helper activity in an in vitro antibody synthesis assay. As 
shown  in Table  VII, culture  supernatants  taken  24  h  after stimulation of these 
T  lymphocyte  clones  by  A/JAP/57  virus-pulsed,  irradiated  syngeneic  spleen 
cells promoted  an in vitro primary anti-SRBC response by T  cell-depleted CB6F~ 
TABLE  VI 
CTL Clones D8 and G1 Are Restricted  to the E~ 
Percent specific 5tCr release from target cells* 
CTL  Effector/  K~*  CA36.2.1  k  n  (E,  Ea)  CA36.1.1 (E,Ea)k  k 
Exp.  clone  target 
ratio  Unin-  Unin-  Unin- 
fected  A/JAP/57  fected  A/JAP/57  fected  A/JAP/57 
1  35-6  2:1  4  19  15  61  4  51 
0.5:1  1  8  4"  29  1  20 
D8  2:1  1  3  8  40  3  5 
0.5:1  0  1  1  12  0  1 
G1  2:1  0  0  6  49  0  2 
0.5:1  0  0  0  16  0  0 
CA36.2.1 "  k a  ~E~Ea) 
Unin- 
fected  A/JAP/57  B/Lee 
2  35-6  5:1  3  24  3 
1:1  0  8  0 
D8  5:1  5  24  8 
1:1  0  7  1 
GI  5:1  2  33  3 
l:l  0  12  0 
U5  5:1  5  8  6 
1:1  0  0  1 
* As in Table I. 
* As in Table I. Spontaneous release from each L cell target was <19%. 
As determined by H-2 restriction in proliferation (47 and Table If), clone 35-6 is restricted by H- 
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TABLE  VII 
Production of B Cell Helper Factors and IL-2 by Class II MHC- 
restricted T Cell Clones 
Culture superna-  Proliferative re- 
tant*  PFC/culture*  PFC/106 cells  sponse of an IL- 
2-dependent 
Clone  Antigen  line  t 
None  -  4 ± 4  47 ± 47  47 + 9 
+  0  0  28---3 
D8  -  7  ---  2  46 ... 13  43 ... 8 
+  65+ 14  181±39  40-2 
G1  -  7+-.2  31...9  48+8 
+  248 ... 0  506 + 0  35 + 5 
U5  -  88 + 2  379 + 9  42 _  5 
+  2,448 + 72  3,060 + 90  52 --- 6 
U11  -  0  0  48 +  13 
+  437 + 20  840 ± 38  6,845 + 290 
* 24 h supernatants were harvested  from cocultures  of cells of the indi- 
cated cloned line with irradiated BALB/c spleen cells that were either 
left untreated (-) or pulsed with inactivated A/JAP/57 virus (+). 
* 8  x  106  T  cell-depleted CB6FI/J  spleen  cells were  cultured in the 
presence of SRBC and 60% T cell clone culture supernatant. After 5 d, 
each culture was harvested  and assayed in duplicate  for an anti-SRBC 
PFC response (Materials and Methods). Values are presented as PFC + 
SEM per culture and PFC +  SEM per 106 viable lymphocytes. Super- 
natant of Con A-pulsed rat splenocytes produced 8,784  ±  108 PFC/ 
culture under these conditions. 
0  IL-2 activity was measured using the IL-2-dependent line 14-7fd as an 
indicator cell. Values are the mean cpm + SEM of quadruplicate cultures 
of 14-7fd ceils in the presence of 50% supernatant of the indicated 
clone. 
spleen cells.  CTL  clone U5  provided the  greatest amount of helper activity in 
this assay system, while CTL clones G1 and D8 promoted a  significant but much 
smaller antibody response.  The  noncytolytic T  cell  clone  U1 1  (Table  I)  also 
generated helper activity after antigenic stimulation. These results demonstrate 
that  the  class  II  MHC-restricted  CTL  clones  secrete  an  antigen-nonspecific 
helper activity after specific antigenic stimulation. 
These same supernatants were also analyzed for  IL-2 activity based on their 
capacity to stimulate proliferation of the murine IL-2-dependent T  cell line 14- 
7fd  (38).  Interestingly, only the  supernatant of antigen-stimulated clone  U11 
contained detectable  IL-2  activity.  After  stimulation with  the  lectin,  Con  A, 
however, all of the class II-restricted clones released significant amounts of IL- 
2 activity (data not shown). 
CTL  Clones Mediate Effector Activity by Direct Lysis of Target Cells.  Since the 
previous results  demonstrated  the  release  of soluble factors  by antigen-stimu- 
lated,  class  II  MHC-restricted  CTL  clones,  it  was  of  interest  to  determine 
whether  their  cytolytic activity could  also  be  mediated  by  a  lymphokine. To LUKACHER  ET  AL.  18! 
investigate this possibility, 51Cr-labeled bystander cells (A20-1.11  cells or P815 
cells)  were  cocultured  with  various  numbers  of unlabeled  A/JAP/57  virus- 
infected A20-1.11  cells in the presence of clones D8, G1, or U5. None of these 
CTL  clones (Fig.  1) showed any cytolytic effect on either  the bystander  A20- 
1.11  or  P815  cells.  Furthermore,  no killing  of these bystander cells by clones 
D8, G1, or U5 was observed even when unlabeled virus-infected A20-1.11  cells 
were present  in  10-fold excess to the bystander  cells.  That  these CTL  clones 
were indeed recognizing  the  virus-infected  A20-1.11  cells was shown by their 
capacity  to  lyse  5~Cr-labeled,  A/JAP/57-infected  A20-1.11  target  cells.  This 
experiment  strongly  suggests  that  these  class  II  MHC-restricted  CTL  clones 
carry out their  cytolytic effector function by direct lysis of virus-infected cells, 
and not by release of a soluble cytolytic factor. 
Discussion 
This report examines the properties of cloned populations of class II MHC- 
restricted, influenza virus-specific CTL. In addition to antigen-specific cytolytic 
effector activity, these T  cell clones share several characteristics  with T  cells of 
the  helper/inducer  subset:  (a)  Lyt-l÷2  -,  L3T4 + cell  surface  phenotype;  (b)  I 
region-restricted recognition of nominal antigen; (c) proliferation in the absence 
of exogenous IL-2; and (d) release of factors that help B cell responses. The class 
I I-restricted CTL clones also demonstrated different patterns of type A influenza 
virus recognition that,  for each clone, were identical for both cellular prolifera- 
tion  and  cell-mediated  cytotoxicity.  Furthermore,  these  clones mediated  their 
cytotoxic effector function by direct lysis of virus-infected cells. 
Using L cell lines expressing transfected class II MHC gene products as target 
cells,  we  have  unambiguously  identified  the  I-E  d  molecule  as  the  restriction 
element for two virus-specific CTL clones. Presentation of influenza viral anti- 
gens by transfected L cells confirms, at the level of target cell recognition, reports 
of Malissen et al.  (40) and Norcross et al. (19) that expression of Ia antigens at 
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FIGURE  1.  Class II MHC-restricted CTL clones do not lyse bystander cells. CTL clones GI 
51  (V'l), D8 (O), and U5 (A) were tested for cytolytic activity on  Cr-labeled bystander cells, (a) 
A20-1.11  cells or (B) P815 cells in the presence of increasing numbers of unlabeled specific 
target cells (A/JAP/57 virus-infected A20-1.11). The ratio of clones to 51Cr-labeled cells is 2 
to 1;  1 X  104 51Cr-labeled cells were added per well. The cytolytic activity of the CTL clones 
on ~lCr-labeled specific target cells (A/JAP/57-infected A20-1.11) is indicated by the closed 
figures (G1 II, D8 0, U5 A). Cloned cells were used 7 d after routine subculturing, and were 
separated from dead ceils on Ficoll/metrizoate gradients before addition to wells. Spontaneous 
release was 30% for A20-1.11 cells and 6% for P815 cells. Assay time was 6 h. Values are the 
means of triplicate wells; SEM, always <5%, are omitted for clarity. 182  H-21  REGION-RESTRICTED  ANTIVIRAL  CTL  CLONES 
the  surface  of  transfected  L  cells  confers  class  II  MHC-restricted  antigen- 
presenting capacity to these nonlymphoid cells. Furthermore, recognition by the 
I-Ed-restricted CTL clones of virus-infected cells of an E~E~k  ~ but not E~E  0k  k L cell 
transfectant  implicates the E~ chain  as the restriction  element for these clones. 
Localization of the restriction element for these clones, however, is complicated 
by  the  finding  that  the  monoclonal  antibody  Do3,  which  specifically  blocks 
cytolytic activity by these clones, reacts with specificity Ia.7, a complex determi- 
nant  on  the  E~  chain  (41).  Since  others  (42,  43)  have  reported  discrepancies 
between serologically defined epitopes on Ia antigens and epitopes on Ia antigens 
recognized  by  T  cells,  monoclonal  antibody-blocking  studies  may  in  some 
instances  represent  a  less satisfactory approach  for  mapping  MHC  restriction 
specificities  than  recognition  of  transfected  cell  lines  expressing  MHC  gene 
products. Similarly, the failure of the anti-I-A  ~ monoclonal antibody MK-D6 to 
block cytolytic activity of an  I-Ad-restricted  CTL  clone may indicate  that  this 
clone  is  restricted  by a  nonoverlapping  epitope  on  the  I-A  a  molecule.  Thus, 
E~E~ transfectant clearly implicates the E~ chain  recognition of the virus-infected  k  d 
as  the  important  restriction  element  in  viral  antigen  recognition  by the  I-E  e- 
restricted CTL clones. This restriction element may be solely on the E~ chain or 
it may be formed by association with the E~ chain.  At present neither possibility 
can be excluded.  In the latter case, it is evident that an E~ chain of either H-2  a 
or H-2 k origin can associate with the E~ chain to generate the restriction site. 
An important  finding is that the class II MHC-restricted CTL clones appear 
to directly lyse virus-infected ceils rather than via the release of a soluble cytolytic 
factor. These CTL exert no cytolytic effect on uninfected bystander cells after 
recognition  of cells expressing appropriate  viral  determinants.  In  this  respect, 
the nature of the cytolytic effector function of the class I-restricted and class II- 
restricted  CTL  clones is  identical.  These  observations  differ  from  the  recent 
results  of Tite  and Janeway  (18)  who  demonstrated  that  I  region-restricted, 
ovalbumin-specific CTL clones mediate their effector activity through a cytolytic 
lymphokine. It appears unlikely that the cytolytic effector activity of CTL clones 
reported  here  is  due  to  antigen-nonspecific  diffusable  lymphokines.  Further 
studies are in progress to better define the mechanism of target cell lysis by these 
class II-restricted,  influenza-specific CTL. 
In  this  report  we  have  also  demonstrated  that  the  class  II-restricted  CTL 
clones secrete a soluble B cell helper activity after specific antigenic stimulation. 
This finding is in agreement with the observations of Dennert et al. (9,  10) that 
a class II MHC-alloreactive CTL line can provide nonspecific help for antibody 
production  in  vitro.  In  addition,  the  class  II-restricted  CTL clones described 
here  may  exhibit  heterogeneity  in  their  capacity  to  help  antibody  responses. 
Based on the yield of PFC per culture and total B cell recovery, several of these 
CTL clones appear to release factors that preferentially induce proliferation  of 
B  cells  over  differentiation  to  antibody-secreting  cells,  whereas  other  clones 
secrete factors that convert a  larger percentage of B cells to antibody-secreting 
cells. Similar clonal variability was observed for antigen-dependent  IL-2 release 
by the  clones.  It  is  not  certain  whether  our  failure  to detect  IL-2  activity  in 
supernatants of the CTL clones reflects an IL-2-independent pathway for prolif- 
eration or consumption of released IL-2 by an autocrine mechanism (44). Since LUKACHER  ET  AL.  183 
all of these class  II-restricted clones can produce IL-2 in response to mitogenic 
stimulation by Con A, and appear to express cell surface receptors for IL-2 (A. 
M.  Churiila, personal communication), the autocrine pathway for endogenous 
IL-2 consumption is the most likely explanation for this result. 
Among the panel of five class II MHC-restricted T  lymphocyte clones exam- 
ined in  this  report,  specific cytolytic activity was exhibited by three of them. 
Preliminary analysis of other Lyt-2-, L3T4 + clones indicates that a  significant 
proportion  of these clones exhibit  class  II-restricted,  influenza virus-specific 
cytolytic activity. Thus it is possible that virus-specific, class  II MHC-restricted 
CTL represent a substantial component of the cellular immune response during 
viral infection. In the mouse, class  I!  MHC-restricted antiviral CTL may have 
gone undetected largely due to  the use of Ia antigen-negative target cells to 
analyze T  cell cytolytic activity (45).  In humans, the use of Ia  + lymphoblastoid 
cell lines as targets allowed our and other laboratories to detect class II MHC- 
restricted antiviral CTL clones (20-22).  Also, it does not appear that cytolytic 
activity is a property only of class II-restricted, influenza-specific T  lymphocytes 
maintained in long-term culture. In preliminary studies, H-2I region-restricted 
killing is detectable in cultures of influenza-immune spleen cells shortly after in 
vitro stimulation with virus (L. A. Morrison, unpublished observations). 
Two of the five class  II-restricted clones examined in  this  report,  U2  and 
U 11, did not lyse virus-infected A20-1.11  targets. This lack of cytolytic activity 
was not a consequence of their inability to recognize this target cell since virus- 
infected A20-1.11  cells could specifically stimulate proliferative responses from 
both the cytolytic and noncytolytic class  II-restricted clones (data not shown). 
Like the CTL clones, these noncytolytic T  cells expressed the Thy-l.2  +,  Lyt- 
1+2 -,  L3T4 + cell surface phenotype, proliferated in response to antigen in the 
absence of exogenous  IL-2,  secreted soluble  nonspecific helper activity upon 
antigenic stimulation, and exhibited a crossreactive pattern of type A influenza 
viral antigen recognition. Taken together, these findings suggest that class  II- 
restricted, virus-specific T  lymphocytes, like class II-alloreactive T  lymphocytes 
(9),  may consist of functionally discrete cytolytic and noncytolytic subsets. This 
distinction provides a possible explanation for differences observed in the effect 
of Lyt-1 + (L3T4 +) T  lymphocytes on  the outcome of viral  infection in  vivo. 
Whether a heterogeneous population of Lyt-1 + T  helper/inducer cells promotes 
recovery from viral  infection (46)  or enhances tissue  injury as a  result  of its 
antiviral effect (34), could depend on the relative proportion of class II-restricted 
cytolytic and noncytolytic clones in the cell innoculum. The relative proportions 
of noncytolytic and cytolytic, influenza virus-specific, class  II-restricted T  lym- 
phocytes generated in response to immunization and infection is currently not 
known. Experiments are underway to determine their frequencies. 
The demonstration in this report of cloned populations of class II-restricted, 
influenza virus-specific murine T  lymphocytes with properties of both T  helper 
lymphocytes and  conventional  CTL,  along  with  recent findings  from  other 
laboratories (8,  10,  18,  19), suggest that the distinction between T  lymphocytes 
of  these  two  subsets  is  not  clear-cut.  More  importantly,  our  findings  raise 
questions regarding the relationship of class I- to class I I-restricted, virus-specific 
CTL, both in terms of their in vivo roles in recovery from viral infection and 184  H-2I REGION-RESTRICTED ANTIVIRAL CTL CLONES 
their  requirements  for  target  cell  recognition.  Studies  currently in  progress 
indicate that cloned populations of class  II-restricted CTL can, upon adoptive 
transfer,  promote recovery of syngeneic recipient mice from lethal  influenza 
virus pneumonia in a  manner similar to that of class  I-restricted antiinfluenza 
CTL clones (28). Moreover, class II-restricted CTL appear to differ markedly 
from class  I-restricted CTL  in  their requirements for influenza viral antigen 
presentation in target cell recognition (manuscript in preparation). The availa- 
bility  of virus-specific,  class  II  MHC-restricted  CTL  clones  should  enable  a 
detailed  characterization  of the  repertoire  of viral  antigenic  specificities,  the 
regulation of expression of effector functions, and the in vivo activities of this T 
lymphocyte subpopulation. 
Summary 
Among murine class  II  major histocompatibility complex (MHC)-restricted 
cytotoxic T  lymphocyte (CTL) clones specific for type A influenza virus, we have 
identified both noncytolytic clones and clones exhibiting H-2 I region-restricted 
cytolytic activity.  After appropriate  antigenic  stimulation,  both  cytolytic and 
noncytolytic clones proliferated in the absence of exogenous interleukin 2.  All 
of the clones possess  the Thy-l.2  +,  Lyt-l+2  -,  L3T4 + phenotype. The class  II 
MHC restriction of viral recognition by the CTL clones was mapped by prolif- 
eration using recombinant mouse strains and by inhibition of cytotoxic activity 
with monoclonal antibodies directed to class II MHC products and L3T4a. The 
restriction specificity of two CTL clones was unambiguously assigned to the Ee  d 
chain by using L cell transfectant lines expressing E~kE¢  d or E~kE~  k gene products. 
Analysis of the viral specificity of the cloned lines revealed subtype-specific and 
crossreactive patterns of viral antigen recognition; the pattern of viral antigen 
specificity exhibited by each clone in proliferation and cell-mediated cytotoxicity 
was identical. Each CTL clone also demonstrated antigen-dependent release of 
helper factor(s) that promoted in vitro primary anti-SRBC responses. Finally, the 
cytotoxic effector function  of the  class  II  MHC-restricted  CTL  clones  was 
mediated by direct lysis of virus-infected cells, and not by secretion of a cytolytic 
lymphokine. 
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